Locally Advanced Pancreatic Cancer

Oncology·MeSH: Neoplasm Metastasis

Prevalence

8.0 / 100K

Incidence

13.1 / 100K/yr

5 drugs in development·4 companies·4 clinical trials

Drug Pipeline by Phase

Phase 2/Phase 3(1)
DrugCompany
sil204Silexion Therapeutics Corp (SLXN)

Compare drugs

FOLFIRINOX chemotherapy vs iagFOLFIRINOX chemotherapy vs rucosopasem manganeseFOLFIRINOX chemotherapy vs sig12d-loder

Frequently asked questions

How many drugs are in development for Locally Advanced Pancreatic Cancer?

BioSniper tracks 5 drugs in development for Locally Advanced Pancreatic Cancer across 4 companies.

How many clinical trials target Locally Advanced Pancreatic Cancer?

There are 4 clinical trials targeting Locally Advanced Pancreatic Cancer tracked by BioSniper.

What is the prevalence of Locally Advanced Pancreatic Cancer?

The estimated prevalence of Locally Advanced Pancreatic Cancer is approximately 8.0 per 100,000 population.

Deep-dive into Locally Advanced Pancreatic Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Locally Advanced Pancreatic Cancer — Drugs in Development & Clinical Trials | BioSniper